Role of excipients on N-oxide raloxifene generation from raloxifene-excipients binary mixtures

Chemical and Pharmaceutical Bulletin

Volumn 57, Issue 10, 2009, Pages 1174-1177

  Yarkala, Sanjeeva ^a,b   Amaravadi, Sivakumar ^a   Rao, Vinay U ^c   Vijaykumar, V ^a   Navalgund, Sameer G ^b   Jagdish, Balasubramaniam ^b  

^a VIT UNIVERSITY   (India)

^b Analytical Chemistry Department   (India)

^c India R and D Center   (India)

Author keywords

Crospovidone; Excipient; N oxide raloxifene; Povidone; Raloxifene HCl

Indexed keywords

CROSPOVIDONE; EXCIPIENT; LACTOSE; MAGNESIUM STEARATE; PEROXIDE; POLYSORBATE 80; POVIDONE; RALOXIFENE;

ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG FORMULATION; DRUG IMPURITY; DRUG OXIDATION; DRUG PURITY; DRUG STABILITY; DRUG STORAGE; EXCIPIENT COMPATIBILITY;

EXCIPIENTS; OXIDATION-REDUCTION; OXIDES; RALOXIFENE; TEMPERATURE; TIME FACTORS;

EID: 70349653475     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.57.1174     Document Type: Article

References (8)

1. Verma R. K., Garg S., J. Pharm. Biomed. Anal., 38, 633-644 (2005).
2. Abdoh A., Al-Omari M. M., Badwan A. A., Jaber A. M., Pharm. Dev Technol., 9, 15-24 (2004).
3. Crowley P., Martini L., Pharm. Technol. Eur., 13, 26-34 (2004).
4. Villalobos-Hernandez J. R., Villafuerte-Robles L., Pharm. Dev. Technol., 6, 551-561 (2001).
5. Loganthan V., Senthilkumar S., Reddy M., Sivaprasadha V., Sreekant N., Ubaidulla U., Manimaran S., Int. J. Pharm. Excip., 2003, 90-94 (2003).
6. Delmas P. D., Bjarnason N. H., Mihak B., Ravoox A. C., Shah A., Huster W., Draper M., Christiansen C,. N. Engl. J. Med., 337, 1641-1647 (1997).
7. Hartauer K. J., Arbuthnot G. N., Baertschi S. W., Johnson R. A., Luke W. D., Person N. G., Rickard E. C., Tingle C. A., Tsang P. K. S., Wiens R. E., Pharm. Dev. Technol., 5, 303-310 (2000).
8. Wasylaschuk W. R., Harmon P. A., Wanger G., Harman A. B., Templeton A. C., Xu H., Reed R. A., J. Pharm. Sci., 96, 106-116 (2007).